Moreover, especially in cutaneous T-cell lymphoma CD26/DPP4 expression patterns emerged as an established marker for diagnosis and treatment monitoring. This evidence concerns the gene DPP4 and primary cutaneous T-cell non-Hodgkin lymphoma.